MYB and neoplasm: In summary, this study demonstrates that the carbazole derivative G51 significantly inhibits c-myb expression and exerts potent anti-tumor activity by simultaneously dismantling the i-motif and stabilizing the G-quadruplex in the c-myb promoter region.